На главную
Результаты поиска “U.S. Pharmaceutical Sales Statistics” за 2017
Big Pharmaceutical Companies Don’t Want You to Watch This Video and Neither Does Your Grandma
Want to be a drug addict? If you live in the U.S. chances are you probably already are. The U.S. - land of the free, of MTV, and of legal drugs. This might just be what makes America great. A place where our doctors prescribe us pills we don’t need for conditions that don’t exist. It’s a win-win. Big Pharma gets bigger and richer and we get higher or just die. Subscribe To My Channel: https://www.youtube.com/channel/UCoFWz1e3VXKOoJ-E5cep1Eg Facebook: https://www.facebook.com/Thought.Monkey.Community/ Instagram: https://www.instagram.com/thought.monkey/ Music: FloFilz - Tilezeit The story was different 50 years ago when Jon went down to his dentist’s office to get his wisdom teeth pulled and the doctor gave him aspirin as pain medication. This was a time when young men went to war and women worked their asses off at home to save the country from collapse. Now? We get high, play video games, watch YouTube, and complain when someone doesn’t call us the right gender. And these days if old Jonny boy goes to the dentist and wants some work done it’s dealers choice. Vicodin. Percocet. Codeine. You name it. Whatever company happens to be in bed with your doctor that day. And if you don’t have private insurance that pays for your drugs? No problem. Sign up for Medicaid. You’ll definitely be able to get free drugs through them. First what exactly is the pharmaceutical industry? To make a long story short it’s a business that creates drugs for use as medications. It’s important to note that it’s not a terrible industry. In fact they have made some very important discoveries like insulin which has saved millions of lives or the countless vaccines that have protected us from at one point, very common diseases like measles and hepatitis. The problem is not the idea of pharmaceuticals – drugs are neither good nor bad. They can either be helpful or dangerous depending on their use. The problem with big pharma is that it is literally killing people. And it’s making a profit doing so. And our government is basically encouraging it. You may ask yourself how an industry that it supposed to be providing us medication which is regulated by the Federal Drug Administration – an organization responsible for “protecting the public health by assuring the safety, efficacy and security of human…drugs,” is killing us. Let’s first look at the health statistics: • 99% of hydrocodone worldwide use is in the U.S – we know this drug more colloquially as Vicodin (which is just a company that makes hydrocodone). This is a drug that the FDA rates as less dangerous as marijuana but in 2011 caused nearly 100,000 emergency department visits. • The U.S. makes up 5% of the world’s population but consumes 80% of its opioid consumption • On average 40 deaths per day are linked to specifically prescription opioids and over 100,000 deaths per year linked with prescription drugs in general. This is far more deaths than what illegal street drugs cause. • Prescription drugs are now the 4th leading cause of death in the U.S. Ok. You get the point. Prescription drugs are dangerous and they are killing people. But now the question is why are people taking them if they’re so dangerous? The answer lies in the incredible reach of big Pharma. The pharmaceutical industry spends between 30 and 60 billion dollars a year on advertising their miracle drugs. You’ve all seen their ads – blue skies, beautiful couple, trees – having trouble sleeping? Bad knees? Buy our pill and feel like new. And then the 10 second list of possible side effects which always include “and in extreme cases, death.” The folks that regulate these advertisements have a budget of $9 million dollars. Do you really think a $9 million dollar budget is enough to regulate something that is more than 6,000 times that size. This is not a David vs. Goliath story. This is an ant vs. an elephant. Big pharma is also notorious for selling drugs that aren’t approved for certain symptoms – a practice called Off-Label Promotion. For example your doctor might prescribe you an antidepressant because she or he believes it will help your migraines. This practice is at times is legal and at others illegal. If illegal you will learn shortly that the fine usually is smaller than the profit these companies make. Big pharma might just consider it another tax of doing business. And yes it has in some cases caused death. There is also the idea that big Pharma creates new illnesses and solves them with their pills. Sounds like a conspiracy theory, right? But actually it makes a lot of sense and you’ve probably seen an ad that talks about some made up illness and a pill to fix it without thinking twice. For example restless leg syndrome. Is that really an illness?
Просмотров: 13284 Thought Monkey
Opioid addiction is the biggest drug epidemic in U.S. history. How’d we get here?
Every day brings another story about the depth of the country’s opioid crisis. A rise of pain killer prescriptions from doctors and a pharmaceutical industry eager to boost sales in the 1990s sparked a wave of addiction that shot up by almost 500 percent in the last 15 years. As a prologue to our series covering the opioid crisis, “America Addicted,” William Brangham reports on how we got here.
Просмотров: 24117 PBS NewsHour
Top 10 Pharmaceutical Companies 2017
The global pharmaceutical market was estimated in USD 1.1 trillion in 2016. The global market is highly mature and consolidated. The top-10 pharmaceutical companies in this market had share of around 40% in 2016 and approximately 50% considering the top-15. A comparative analysis of the top-15 organizations was used to develop a ranking for these companies. http://igeahub.com/2017/03/14/top-10-pharmaceutical-companies-2017
Просмотров: 34730 IgeaHub
How Does German Economy Compare to United States Economy?
How do US economy and German Economy compare? Can German economy beat United States economy soon? 🐻 SUBSCRIBE TO OUR NEW CHANNEL: Fuzzy & Nutz 🐿️ ►►► http://bit.ly/fuzzyandnutz WEBSITE (You can suggest a topic): http://theinfographicsshow.com SUPPORT US: Patreon.......► https://www.patreon.com/theinfographicsshow CHAT: DISCORD.....►https://discord.gg/theinfographicsshow SOCIAL: Facebook...► https://facebook.com/TheInfographicsShow Instagram..► https://www.instagram.com/theinfographicsshow Twitter........► https://twitter.com/TheInfoShow Subreddit...► http://reddit.com/r/TheInfographicsShow -------------------------------------------------------------------------- Sources for this episode: https://pastebin.com/NMWsUwcm
Просмотров: 560473 The Infographics Show
Law enforcement warning about dangers of buying prescription drugs online
CINCINNATI (WKRC) - With prices for some drugs going sky high, some people turn to the internet looking to save money on prescriptions, but beware, criminals are waiting to take advantage of anyone they can. Law enforcement is cracking down on and now warning consumers about the dangers of buying drugs over the internet. A few surveillance photos show a postal customer who sent almost 80 packages daily from the post office. Inside of the packages were counterfeit drugs mailed by Shoaib Haroown. Thomas Halsell, a US Postal Inspector, said "We found Mr. Haroown receiving orders and then supplying those orders out to customers that had offered pharmaceutical pills on websites or online pharmacies." Consumers may order the drugs online in an effort to save money, but make no mistake, the move is like playing "Russian Roulette." "They were receiving packages with pills in them that were in Ziploc bags. They weren't marking with what they were. They had no instructions with them. They had no side effects. They had no warnings," Halsell added. Dale Forrester, a USPIS Sr. Forensic Chemist, said "You may receive the actual compound and you may not. You may receive something that's deadly to you." A search warrant of Haroown's home showed random uncounted pills, credit card numbers, and passports in his home. Law enforcement cannot emphasize enough that you are gambling with your life by taking drugs that don't follow legal standards. One of the things to make sure of is if they ask for your doctor's prescription, that when the package is received, it actually comes in some type of self-locking mechanism, particularly the brown bottles with the interlocking caps. It needs to have the doctor's name on it, the type of pill that's inside of it, the daily dosage, the side effects, warnings, and the list of active ingredients. Mr. Haroown was sentenced to five years in federal prison.
Просмотров: 4004 LOCAL 12
Global Pepsin Market 2017-2022 Growth, Trends and Demands Research Report
The report provides key statistics on the market status of the Global Pepsin manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Complete report on Global Pepsin market spreads across 116 pages profiling 14 companies and supported with 160 tables and figures @ http://www.reportsnreports.com/contacts/discount.aspx?name=864139 . Key Companies Analysis:-Constantino & C.(IT), BIOZYM(DE), Enzymology Research Center(US), Lee Biosolutions(US), Mitushi Pharma(IN), Meteoric Life sciences(IN), Feideli Pharmaceutical, Deyang Sinozyme, Sichuan Deebio Pharmaceutical, Chongqing quanxinxiangsheng, Zhengzhou Longhe Chemical, Sichuan Biosyn Pharmaceutical, ChongqingJingkang and Biotechnology. The Global Pepsin Industry provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.The Global Pepsin market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The Global Pepsin Industry focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information.Upstream raw materials and equipment and downstream demand analysis is also carried out. The Global Pepsin industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. With the tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. Place a Direct Purchase on this Report @ http://www.reportsnreports.com/purchase.aspx?name=864139 . Major Points Covered in Table of Contents: 1 Industry Overview 2 Manufacturing Cost Structure Analysis of Global Pepsin 3 Technical Data and Manufacturing Plants Analysis 4 Production Analysis of Global Pepsin by Regions, Technology, and Applications 5 Sales and Revenue Analysis of Global Pepsin by Regions 6 Analyses of Global Pepsin Production,Supply,Sales and Market Status 2010-2017 7 Analysis of Global Pepsin industry Key Manufacturers 8 Price and Gross Margin Analysis 9 Marketing Traders or Distributor Analysis of Global Pepsin 10 Development Trend of Global Pepsin industry2017-2022 11 Industry Chain Suppliers of Global Pepsin with Contact Information 12 New Project Investment Feasibility Analysis of Global Pepsin 13 Conclusion of the Global Global Pepsin industry 2017 Market Research Report List of Tables and Figures Get more details on this report @ http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=864139 . About Us: Reports n Reports is digital databank of syndicated market reports for worldwide and China businesses. ReportsnReports.com offers market research reports to businesses, entities and organizations with an objective of assisting them in their decision making process.Our collection of 500,000+ industry & nation research reports shields 5000+ micro markets. We provide 24X7 available, online and offline support to our clients. Contact: Ritesh Tiwari UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar, Pune, Maharashtra 411013, India Tel: +1-888-391-5441 sales@reportsandreports.com
Просмотров: 17 kalpesh vora
The most addictive prescription drugs on the market
The most addictive prescription drugs on the market Prescription Drug Addictions Just because pills are prescribed by a doctor and administered by a pharmacy, that doesn’t mean they are safe for everyone. As prescription numbers continue to rise, the c...
Просмотров: 6 Kita TV
How Big Pharma Created the Heroin Epidemic
Mike Papantonio discusses the factors that led to the current opioid crisis in the U.S. and speaks with attorney Jeff Gaddy about a lawsuit being brought by the Cherokee Nation against several pharmaceutical companies. FOLLOW Mike Papantonio on Twitter: https://twitter.com/americaslawyer FOLLOW America’s Lawyer on Facebook: http://www.facebook.com/rtamericaslawyer Find RT America in your area: http://rt.com/where-to-watch/ Or watch us online: http://rt.com/on-air/rt-america-air/ Like us on Facebook http://www.facebook.com/RTAmerica Follow us on Twitter http://twitter.com/RT_America
Просмотров: 9361 RT America
Canadian Drug Prices: 2nd Highest Behind the United States
Canadians are still paying more for generic drugs than those in foreign markets thanks to a pricing model that one expert calls "uniquely stupid." As outrage continues to gather in the US over "pharma bro" Martin Shkreli and price gouging, a new report released this week found wild discrepancies in the cost of generics in Canada versus outside. The Patented Medicine Prices Review Board (http://pmprb-cepmb.gc.ca/home), Canada's drug price watchdog, compared the cost of 554 leading generic drugs — substances that treat everything from cardiovascular and gastrointestinal ailments to central nervous system conditions and diabetes — in Canada to those in 11 other industrialized countries, including the US, a number of European countries, as well as Australia and New Zealand. "Nobody in the world is as foolish in how they buy generic drugs are we are," says Amir Attaran, a law professor at the University of Ottawa and Canada Research Chair in law, population health and global development policy, in an interview. The higher prices are costing the Canadian taxpayer a billion dollars a year, and generics companies "are laughing at us," said Attaran. In Canada, prices are determined by provinces and territories, which commit to paying a certain percentage of the cost of brand name drugs for the generic versions. In Saskatchewan, for example, that price is 25 percent of the cost of brand name products. Ontario, on the other hand, now has a tiered pricing system. For example, if there are two existing sources for generics, the province would pay half of the branded price. If there are three or more sources, the amount drops. For 14 of the most common generic drugs — used to treat a variety of conditions including high cholesterol, high blood pressure, nerve pain, and diabetes — provinces and territories have formed the pan-Canadian Pharmaceutical Alliance (pCPA) to buy in bulk at 18 percent of the cost of an equivalent brand name product. "This percentage targeting is plain stupid," said Attaran. "It's the wrong way to do it because [the percentage] may give you a perfectly reasonable price or it may be too high for other medicines. It may also be too low for others, and if it's too low, no one's going to sell to you." He called the percentages arbitrary and compared the system to a dealership selling all used cars at 25 percent the cost of a new car. "That's a great deal if the used car is a year old and in mint shape, but what if the thing is a 20-year-old wreck?" Drug price gouging made headlines last year after Martin Shkreli jacked up the price of a patented drug used to treat parasitic infections by more than 5,500 percent. The impact of this price difference is ultimately felt by the consumer, said Joel Lexchin, who teaches health policy at York University in Toronto. "If you're paying out of pocket, you're paying more, and if you're getting your drugs covered through private insurance, your premiums are higher," he explained. If your medication is covered by a provincial drug plan, Lexchin continued, you're paying more in tax dollars. Tax dollars could also cover a wider range of drugs if the prices of generics are lowered. According to both Lexchin and Attaran, Canada would do well to look to New Zealand's system of tendering — in which the country announces the need for a certain drug, lets suppliers compete and chooses the lowest bidder — as an example for how drug price regulations can be improved. The model "gives companies the best price forward because if they get the deal, they're supplying all of New Zealand," Attaran explained. "What they lose in profit margin, they gain in volume." But Lexchin cautioned that having a single supplier for a particular drug also has its risks. There must be safety mechanisms in place in case of an emergency, like a fire at a manufacturing plant, which would prevent the production of and access to the drug, he said. Universal prescription drug coverage in Canada: Long-promised yet undelivered https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5094297/ Health minister vows to save Canadians 'billions' on drug prices http://www.cbc.ca/news/health/health-minister-jane-philpott-drug-prices-1.3932254 Federal health minister plans to save billions on drug prices, but needs to commit to pharmacare https://canadians.org/blog/federal-health-minister-plans-save-billions-drug-prices-needs-commit-pharmacare Provincial and Territorial Public Drug Benefit Programs http://www.hc-sc.gc.ca/hcs-sss/pharma/acces/ptprog-eng.php
Просмотров: 160 Our Amazing World
Joe Rogan Reacts To Ridiculous Pharmaceutical Adverts!
Joe Rogan and Chris Kresser watch and react to ridiculous TV adverts of pharmaceuticals on the Joe Rogan Experience Podcast, JRE 1037. Full podcast - https://www.youtube.com/watch?v=bYOIhmZ0Osg Joe Rogan and Chris Kresser watch and react to some crazy TB adverts by pharmaceutical companies in America. Both Joe Rogan and Chris Kresser think it's insane that these pharmaceutical companies advertise to people in this way, especially when their products haven't even been properly tested for the conditions they're advertised as curing. Joe Rogan talks about health, pharmaceutical companies, big pharma, diet, exercise, mental health, pharmaceutical adverts and other topics with Chris Kresser on the Joe Rogan Experience podcast, JRE 1037. Joe Rogan Reacts To Ridiculous Pharmaceutical Adverts! - https://www.youtube.com/watch?v=143TX0cU-fI
Просмотров: 92961 Joe Rogan Fan Page
General Electric: Digital Transformation and the Sales Force (CXOTalk #266)
How is one of the largest companies in the world evolving the way it sells? Cate Gutowski, Vice President, Commercial & digital THREAD at General Electric, speaks with CXOTalk about digital transformation of the global salesforce at General Electric, and the changing relationship between sales and IT. For more information: https://www.cxotalk.com/episode/ge-digital-transformation-global-salesforce Gutowski, who has worked at GE for two decades, explains the sales function is about to undergo the biggest transformation in the history of selling: “We are driving the digital transformation of our sales force by activating the Commercial digital THREAD, a connected digital ecosystem that will enable our Field Sales professionals to serve our customers with speed, and drive growth,” she says. “My team of Product Managers incubates new technologies in Artificial Intelligence, Machine Learning, and Predictive Analytics to rapidly test and learn on how we can drive more productivity for our 25,000 sellers across 180 countries. Our mission is to enable our Field Sales teams all over the world to do their jobs simpler, faster and better than they could before by leveraging technology.” From the transcript: You're working closely with IT and the CIO. Why is that so important? Cate Gutowski: Yeah, great question, Michael. I love that question. Look; one of the things I'm convinced of is that all future sales leaders, I think, in order to be successful, you really need to have a very close working partnership with your CIO. Look; there's a lot of technology that exists today. It exists right now. It's on the market right now that can dramatically change your sales process and make you significantly more efficient and make your sales teams more productive. The problem is a lot of us quite simply don't like change. And so, for me, it's been fantastic. I almost felt like an IT wannabe. I've spent a lot of time with the IT team. What I can tell you is that they're incredible partners. Any job I ever take in the future, I'm going to make sure that I have the opportunity to really develop a close partnership because I can see how it can be incredibly productive. Michael Krigsman: We have IT. These all, each of these groups, have its own objective, its own KPIs. How do you manage the collaboration? How do you do that? Cate Gutowski: Yes, it's a good question. When I was asked to lead this digital transformation, chose to organize my team as product management. I have product managers that wake up every morning that are focused on different areas. They partner with a lot of technology companies. We make decisions every day, Michael. Are we going to build, make, or buy technologies? In some cases things are strategic and we want to have the IP around it. We feel like we can execute it faster than someone else, and so we'll choose to do it on our own. But, in a lot of cases, there's a lot. The sales technology landscape is exploding right now, and there are a lot of great technology, like tact.ai, for example, that exists that it's cheaper, faster, and better for us to partner with a company like Tact to bring a product like the GE Digital Assistant to market and to our sales professionals than it would be to try to create it on our own. I'm embarrassed to say that we didn't have a system to manage all of our customer data all across the company. The outcome of that is staggering. We know that our sales teams spend two-thirds of their time today on administrative tasks and only one-third of their time face-to-face with customers. We know that when our sales team spends more time in front of our customers, we know that they sell more. We've proven that with statistics and regression analysis, and we know that cold. What was important to us was, look, Michael. I was building the things that I always wanted when I was selling and leading the sales organization. I'll give you an example. I came from the lighting business. When I was in lighting, I wanted to leverage the GE store. I wanted to leverage the contacts that someone in oil and gas had with Exxon Mobile. And, I wanted to get a warm introduction to Exxon Mobile. In the past, I would spend three weeks, on average, calling and emailing around the company to try to find the right person that could give me a warm introduction. The reality is that that's just not efficient, and it's not productive. The reason why we invested time and money to put this customer data set altogether for the company is because now if I want to get a warm introduction to Exxon Mobile, I can find the information in seconds, and I can see who are the 12 people in the company who have active deals with Exxon Mobile, who are they working with, what's the job, how big is it. I can see all of that, whereas in the past it was like finding a needle in a haystack, Michael.
Просмотров: 7261 CXOTALK
Christi Shaw: We need to stop focusing on quarterly numbers
Christi Shaw, former President of US, Novartis speaking at eyeforpharma Philadelphia on how pharma needs to go beyond focusing on quarterly numbers to having the empathy to truly understand patients. eyeforpharma’s youtube channel now broadcasts the best presentations, chats and interviews from our conferences. eyeforpharma’s mission is to make the pharmaceutical industry more open and valued. Our conferences are where leading minds gather to discuss and share strategies that drive value for patients and shine a light on pharma excellence. Look for talks on patient-centricity, multi-channel marketing, value-added services, real-world data and sales force effectiveness. Get the latest industry insights in your inbox: http://social.eyeforpharma.com/ Follow eyeforpharma on Twitter: http://www.twitter.com/eyeforpharma Like eyeforpharma on Facebook: http://www.facebook.com/eyeforpharma Subscribe to our channel: http://www.youtube.com/user/eyeforpharma
Просмотров: 154 eyeforpharma
Digitalization in Pharma | 25 April 2017 - 12:00 am
How digitalization is transforming the Pharma Industry, including concrete examples of how our customers are using our technology to build their visions of the pharmaceutical plant of the future.. Find all presentations for download under https://www.siemens.com/hm17-program
Просмотров: 456 Siemens
Corruption or cure? Russia's pharmaceutical dispute
Russian lawmakers have asked doctors to prescribe a medication which has been manufactured by a pharma company that has bogus research data.
Просмотров: 103 ZoominTV
why prescription drugs didn't work to eliminate knee pain (The Knee Pain Guru)
Here's why prescription drugs didn't work to eliminate knee pain. The Knee Pain Guru is the best in the world at eliminating knee pain without prescription drugs, pain killing shots or surgery. For other great resources on prescription drugs for eliminating knee pain see the following links: Prescription Drugs & Cold Medicines - National Institute on Drug Abuse https://www.drugabuse.gov/drugs-abuse/prescription-drugs-cold-medicines Opioids include: Fentanyl (Duragesic®) Hydrocodone (Vicodin®) Oxycodone (OxyContin®) Oxymorphone (Opana®) Propoxyphene (Darvon®) Hydromorphone (Dilaudid®) Meperidine (Demerol®) Diphenoxylate (Lomotil®) Prescription Drugs | NIDA for Teens https://teens.drugabuse.gov/taxonomy/term/396 Visit our separate Drug Facts pages to learn more about each of these classes of prescription drugs: Opioids—used to relieve pain, such as Vicodin, OxyContin, or codeine. Depressants—used to relieve anxiety or help a person sleep, such as Valium or Xanax. WebMD Drugs & Medications - Medical information on prescription ... https://www.webmd.com/drugs/2/index Answer your medical questions on prescription drugs, vitamins and Over the Counter medications. Find medical information, terminology and advice including side effects, drug interactions, user ratings and reviews, medication over dose, warnings and uses. ‎Drugs & Medications AZ · ‎Pill Identifier · ‎Gabapentin · ‎Abilify Top stories Teen arrested for selling prescription drugs WEAR 18 hours ago How Amazon could completely disrupt the prescription drug industry The Week 6 hours ago Suspect wanted for breaking into car, stealing money and prescription drugs WACH.com 6 hours ago More for prescription drugs WebMD Drugs & Medications – Medical information on prescription ... https://www.webmd.com/drugs/2/alpha/i/ Answer your medical questions on prescription drugs, vitamins and Over the Counter medications. Find medical information, terminology and advice including side effects, drug interactions, user ratings and reviews, medication over dose, warnings and uses. Buy Cheap Prescription Drugs Online | PlanetDrugsDirect.com https://www.planetdrugsdirect.com/prescription-drugs Save up to 80% when buying prescription drugs online. PlanetDrugsDirect has served over 100000 customers in the US. Canadian prescription drug referral service. RxList - The Internet Drug Index for prescription drugs, medications ... https://www.rxlist.com/ Read doctor-produced health and medical information written for you to make informed decisions about your health concerns. Prescription drug - Wikipedia https://en.wikipedia.org/wiki/Prescription_drug A prescription drug is a pharmaceutical drug that legally requires a medical prescription to be dispensed. In contrast, over-the-counter drugs can be obtained without a prescription. The reason for this difference in substance control is the potential scope of misuse, from drug abuse to practicing medicine without a license ... A - Z Drug List from Drugs.com https://www.drugs.com/drug_information.html A to Z list of over 24000 prescription and over-the-counter medicines for both consumers and healthcare professionals. The Myth of Drug Expiration Dates — ProPublica https://www.propublica.org/article/the-myth-of-drug-expiration-dates The box of prescription drugs had been forgotten in a back closet of a retail pharmacy for so long that some of the pills predated the 1969 moon landing. Most were 30 to 40 years past their expiration dates — possibly toxic, probably worthless. But to Lee Cantrell, who helps run the California Poison Control ... What's really causing the prescription drug crisis? - LA Times www.latimes.com/.../op.../la-oe-hari-prescription-drug-crisis-cause-20170112-story.html There are two quite different stories about why there is a prescription drug crisis in the United States, and why opioid-related deaths have quadrupled since 1999. At some level, you are probably aware of both. Earlier this year, I interviewed people in the New Hampshire towns worst affected by this crisis ... Amazon illegal drugs: Muscle relaxants, steroids, prescription drugs ... www.slate.com/.../amazon_illegal_drugs_muscle_relaxants_steroids_prescription_drugs... I have by no means executed a comprehensive search of wares sold by Amazon directly or through its third-party sellers, but I found other prescription drugs for sale without a prescription, including the antibiotic norfloxacin and the muscle relaxant methocarbamol. Both compounds, like clindamycin, warrant ... Searches related to prescription drugs prescription drugs abuse prescription drugs list prescription drugs online prescription drug abuse facts prescription drugs abuse list prescription drug abuse statistics prescription drugs examples prescription drug prices
Просмотров: 71 Bill - The Knee Pain Guru
Medical Devices Market: 2017 Global Industry Trends, Growth, Share, Size and 2021 Forecasts Report
Global Medical Devices Market Report: 2017 Edition research of 76 pages with 48 Charts and 2 Tables, 4 company profiles to the Medical Devices industry segment of its online data and intelligence library, now available at http://www.marketreportsonline.com/580819.html
Просмотров: 59 smith Jones
ADDICTS LIVES MATTER Is not, in any way promoting Drug use of any kind. This channel is about Awareness, Education, Breaking the stigma and Helping those who struggle with Addiction. Gwen Olsen — INDUSTRY’S INFLUENCE IN MEDICINE DUPED, DOPED AND DYING IN AMERICA On December 2, 2004, Gwen Olsen's niece Megan committed suicide by setting herself on fire-and ended her tortured life as a victim of the adverse effects of prescription drugs. Gwen Olsen offers an honest glimpse into alarming statistics and a health care system ranked last among nineteen industrialized nations worldwide. As a former sales representative in the pharmaceutical industry for several years, Olsen learned first hand how an unprecedented number of lethal drugs are unleashed in the United States market, but her most heartrending education into the dangers of antidepressants would come as a victim and ultimately, as a survivor. Gwen Olsen shares one woman's unforgettable journey of faith, forgiveness, and healing. ADDICTS LIVES MATTER WATCH MORE VIDEOS https://www.youtube.com/playlist?list=PLvOiLFkOlXFzXlVmwPgw7lg6MxqkchIDo Category Education License Standard YouTube License
Просмотров: 2804 AddictsLivesMatter
Pfizer Pharmaceutical: Patient Experience and Innovation (CXOTalk #265)
The pharmaceutical industry is evolving to consider customer experience – or patient experience, in this case – as a core dimension when bringing new drugs to market. Shifting consumer expectations combined with innovative technologies will have a dramatic impact on drugs and healthcare in the coming years. On this episode of CXOTalk, industry analyst Michael Krigsman speaks with two strong voices on this important issue. For more information: https://www.cxotalk.com/episode/big-pharma-patient-experience-innovation Craig Lipset is Head of Clinical Innovation within Worldwide Research & Development at Pfizer. Craig’s team is responsible for impacting clinical research through digital tools, innovative research approaches and novel collaborations. Michael DePalma works at IQVIA as Vice President of Digital Transformation. From the transcript: Craig Lipset: (00:04:14) I think that there are a lot of buzzwords that all of our different industries face. Right now, in many ways, patient centricity, which has been a buzzword, is actually starting to come into action. It's easy to say that we do things for patients. It's kind of like saying I love puppies and babies. Of course, I'm going to do the right thing for patients, but do you really in terms of the level of complexity that you've created for people? (00:04:41) I work on the clinical trials that we've got going on here at Pfizer. When you look at the historical amount of burden to patients to find a trial, to participate in a trial, to keep coming in and out, the amount of data that was extracted from patients, all of that, it makes it very hard to say that the historical approach for running these studies is very patient-centric. I think it's really embodied in the word "subject." (00:05:07) When you look at most of the studies that are performed around the world, the majority still use that term, "subject," which is a very hierarchical term. To me, it implies almost like a subject that you're trying to paint. You're drawing data out of it, and you're giving very little in return, as compared with a more contemporary view of looking at patients as participants in the process. Michael Krigsman: (00:05:32) Michael, I know you have thoughts on this. [Laughter] Michael DePalma: (00:05:34) I have a lot of thoughts on this. Let me begin by telling you a little bit about what I do at IQVIA because I think it plays into this. I run digital transformation and partnerships at IQVIA. What that means is, how do we find new ways to solve old challenges or, quite frankly, how do we use technology or new methods to create solutions for challenges we haven't yet really experienced but we kind of see coming down the pike? (00:05:59) This patient experience conversation--and Craig and I have talked about this a whole bunch--is one of those funny things. We had a conversation earlier. Words matter and we use the word "subject." (00:06:09) It's funny. Actually, Craig, you used the word "data extracted" from patients, right? That's a really funny word. We extract data from patients. It's really unnerving to kind of think about it that way. (00:06:20) The question is: are you a human; are you a patient; are you a subject; are you a consumer? As it turns out, you're all of those things. And so, the nomenclature matters, and it also affects, I think, the way that we think about ourselves and the way that we think about the people that we're trying to serve. When we get into that area and we talk about subjects, we talk about data, the question is, how can we as an industry create an environment where human beings feel much more comfortable and confident in receiving care, in engaging with care, in sharing information, and creating that sort of 21st Century environment? (00:12:47) When we talk about collaboration, the first thing is to look at these human beings, patients. Patients are just sick humans, right? It's a temporary thing, we hope. They are consumers. They have certain expectations about the way the world works, about what they can expect. (00:13:02) If you look at the way that collaboration and access and democratization has occurred in places like finance, education, and all these other areas, healthcare still lags a bit, and we're still working on that. But, there are some really, really, I think, encouraging signs when I looked at some recent data. Sixty percent of patients say that they are more than willing to have a video consultation with their healthcare provider. Eighty-eight percent of them said that they were absolutely willing to share their health data if it helped accelerate cures. (00:13:32) I look at that, and I say, "All right, there's a little bit of a disconnect there because A) Are we doing that? B) Are we doing that the way that these consumers understand that we're doing that?
Просмотров: 6726 CXOTALK
Free Pills From Illegal Pharmacy Part #2
After 2 weeks of autodialing this illegal pharmacy the guy coulnd't stand it anymore... His bussiness started to suffer cause of our efforts, to bad for him... We actually managed to get free medicines from this company, we have to get it tested to see if they are counterfeits or not. PART 2 We dial all kinds of scammers LIVE non stop 24/7 to raise awareness and to waste their time so they get to scam less people. The more we dial them, the less chance they get to scam someone. These people make alot of victims and are mostly based in India, and not much is done by the authorities.... we try to make a difference! Please subscribe & share this stream to spread the word! Every time their phones ring they will wonder if it will be a victim or one of us ! We bait, we troll, we prank, anything to prevent innocent people from being robbed! Tech support scammers, IRS calls, fake cruise scammers, if they scam trough phone we dial them! Please watch out 24/7 livestream @ http://deeveeaar.com Discord :https://discord.gg/N79Brkd Facebook: http://facebook.com/deeveeaar Twitter: http://twitter.com/deeveeaar Donate: http://streamlabs.com/deeveeaar merchandise: http://deeveeaar.spreadshirt.co.uk scammer numbers: http://Scammer.info
Просмотров: 1681 Deeveeaar
Countdown: 7 November 2017
Assessing the impact on Lupin post U.S. FDA warning letter, decoding the buzz behind EIL & more.
Просмотров: 417 BloombergQuint
Global Calcium Sulphate Market 2017-2022 Growth, Trends and Demands Research Report
The report provides key statistics on the market status of the Global Calcium Sulphate manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry. Complete report on Global Calcium Sulphate market spreads across 101 pages profiling 09 companies and supported with 160 tables and figures @ http://www.reportsnreports.com/contacts/discount.aspx?name=1053078 . Key Companies Analysis:-Neelkanth Chemicals, W.A. Hammond Drierite Co, Noah Technologies Corporation, Spectrum Chemical Manufacturing Corp, Nikunj Chemicals, Sigma-Aldrich Co, Hebei Xingtai Shuanghua Gypsum Products Co, GLC Minerals, GFS Chemical AND Mionix LLC. The Global Calcium Sulphate Industry provides a basic overview of the industry including definitions, classifications, applications and industry chain structure. The Global Calcium Sulphate market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand Figures, cost, price, revenue and gross margins. The Global Calcium Sulphate Industry focuses on global major leading industry players providing information such as company profiles, product picture and specification, capacity, production, price, cost, revenue and contact information.Upstream raw materials and equipment and downstream demand analysis is also carried out. The Global Calcium Sulphate industry development trends and marketing channels are analyzed. Finally the feasibility of new investment projects are assessed and overall research conclusions offered. With the tables and figures the report provides key statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market. Place a Direct Purchase on this Report @ http://www.reportsnreports.com/purchase.aspx?name=1053078 . Major Points Covered in Table of Contents: 1 Industry Overview 2 Manufacturing Cost Structure Analysis of Global Calcium Sulphate 3 Technical Data and Manufacturing Plants Analysis 4 Production Analysis of Global Calcium Sulphate by Regions, Technology, and Applications 5 Sales and Revenue Analysis of Global Calcium Sulphate by Regions 6 Analyses of Global Calcium Sulphate Production, Supply, Sales and Market Status 2010-2017 7 Analysis of Global Calcium Sulphate industry Key Manufacturers 8 Price and Gross Margin Analysis 9 Marketing Traders or Distributor Analysis of Global Calcium Sulphate 10 Development Trend of Global Calcium Sulphate industry2017-2022 11 Industry Chain Suppliers of Global Calcium Sulphate with Contact Information 12 New Project Investment Feasibility Analysis of Global Calcium Sulphate 13 Conclusion of the Global Global Calcium Sulphate industry 2017 Market Research Report List of Tables and Figures Get more details on this report @ http://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=1053078 . About Us: Reports n Reports is digital databank of syndicated market reports for worldwide and China businesses. ReportsnReports.com offers market research reports to businesses, entities and organizations with an objective of assisting them in their decision making process.Our collection of 500,000+ industry & nation research reports shields 5000+ micro markets. We provide 24X7 available, online and offline support to our clients. Contact: Ritesh Tiwari UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar, Pune, Maharashtra 411013, India Tel: +1-888-391-5441 sales@reportsandreports.com
Просмотров: 9 kalpesh vora
Chinese pharmaceutical producers see decreasing exports, rising costs
Chinese pharmaceutical producers see decreasing exports, rising costs SUBSCRIBE my channel here: https://goo.gl/F8gn4Z Source video: http://c.newsnow.co.uk/A/2/905432706?-40578:27111:3 G+ here: https://goo.gl/UzMJVe ---------------------------------------------------------------------------------------------------- Photo VCG Political tension between India and China has hurt the drug exporting business of some Chinese companies, as domestic drug exporters told the Global Times that they have seen decreasing exports and rising costs in the Indian market. A Guangdong pharmaceutical sales manager told the Global Times on Sunday that his companys exports to India have decreased and the company might turn to other markets if the situation worsens. Another sales manager who declined to be identified and works in a Hangzhoubased pharmaceutical company told the Global Times that his company has seen rising costs in the Indian market since the border standoff. According to a report of the Times of India on Sunday, the Indian government is developing measures to reduce the countrys dependence on imports of pharmaceutical products, including active pharmaceutical ingredients APIs, from China. A drug sales manager who only gave his surname as Guo and who works at a pharmaceutical company based in Shenzhen, South Chinas Guangdong Province, told the Global Times on Sunday that the exports of his companys pharmaceutical products to India have decreased in recent months. Political tensions between China and India did have an impact on exports, Guo said, although he declined to reveal the specific decrease in export volumes to the Indian market. Guos company started expanding in the Indian market a decade ago, and it exports more than 1,000 kinds of products to the country, including pharmaceutical raw materials, medical products and agricultural chemicals. My company will try to shift its focus from the Indian market to other foreign markets if exports continue to decline after India decides to cut imports from China, Guo noted. The sales manager of the aforementioned Hangzhoubased pharmaceuticals company told the Global Times that its export volume to India seems to have been unaffected by the political tension. But each business that my company is involved in India had to be insured after July when bilateral political tension intensified, which to some extent, increased the cost, he said. He said that his company primarily exports vitamin products to India, a busine... ----------------------------------------------------------------------------------------------------
Просмотров: 127 Hot News
Ohio SUES 5 Pharmaceutical Companies Over OPIOID DEATHS!
▶▶▶ SUBSCRIBE TO MY SECONDARY CHANNEL FOR CRYPTO NEWS! https://www.youtube.com/c/KuberaYT ►► My Instagram - https://www.instagram.com/AVILSD/ ▶ Business Email - tychebitcoins@gmail.com Ohio sues 5 pharmaceutical companies as the death toll rises to astonishing numbers from drug overdoses. 2017 is looking like it's going to be the worst year yet, as America is approaching slowly but steadily 100,000 drug overdose deaths every year. Opioids are the biggest killer, but many people don't realize the severity of this crisis. This affects everybody, from your grandma to your friends to even your pets. Doctors all across the nation are overprescribing, companies are encouraging this by producing more and paying out more, and even the consumer is at fault. The war on drugs has failed. It's time to fight back though against this stuff, as it's not just a homeless heroin junkie we're talking about now.. it's everyone. Canada and America are being devastated by Fentanyl, Oxycodone and Hydrocodone. If you use opioids/opiates, or know anybody that does, you NEED to watch this: https://www.youtube.com/watch?v=d6QTAKnN8B8 Links: https://www.nytimes.com/interactive/2017/06/05/upshot/opioid-epidemic-drug-overdose-deaths-are-rising-faster-than-ever.html?mcubz=2 https://www.nytimes.com/2017/05/31/us/ohio-sues-pharmaceutical-drug-opioid-epidemic-mike-dewine.html http://www.cleveland.com/metro/index.ssf/2017/05/ohios_opioid_lawsuit_against_5.html If you enjoyed my content, please leave a like, comment and subscribe for more! Sharing this video also helps incredibly and I appreciate it if you do, as it certainly aids in my channel's growth! ▶ You can also support my channel by going to my Patreon ✔ if you'd be able to: ▶ ▶ ▶ https://www.patreon.com/AVILSD ❤THANK YOU!! ► My YouNow - https://www.younow.com/AVILSD/ ► My Instagram - https://www.instagram.com/AVILSD/ ► My Twitter - https://twitter.com/MDMA ► If you'd like to, also check out my secondary and backup channel: https://www.youtube.com/c/AVILSD2 ► My Steemit - https://steemit.com/@avilsd (Steemit is a site similar to reddit, but if you upvote my stuff I have a chance of earning a small amount of crypto which can then in turn be transformed into $) ▶ You can also support my channel by shopping on Amazon ✔ using my link for ANYTHING: ▶ ▶ ▶ https://goo.gl/DmEHFg ❤THANK YOU!! ► ► Weigh your substances w/ this scale: American Weigh Milligram Scale - https://goo.gl/QgNIo4 ❤ ► ► ► Test your substances with reagent kits from Amazon: Marquis - https://goo.gl/C8nWqM ❤ Marquis + Simons - https://goo.gl/ADbhRb ❤ Ehrlich - https://goo.gl/8LctaY ❤ Mandelin - https://goo.gl/7Pva16 ❤ Mecke - https://goo.gl/9eCLqQ ❤ Simons A + B - https://goo.gl/EsJ1b1 ❤ Marquis, Mecke, Simons, Mandelin and Ehrlich - https://goo.gl/1gedZL ❤ THE ONES BELOW ARE NOT STANDALONE TESTS!!!! Froehde - https://goo.gl/ZxTmqI ❤ Liebermann - https://goo.gl/iW3asZ ❤ Hoffman - https://goo.gl/FxJ6EQ ❤ Music: n/a (Intro - Chris Zabriskie "There's A Special Place For Some People") (Outro - OBESØN - Drugs) Ohio sues 5 companies due to opioid deaths -~-~~-~~~-~~-~- Please watch: "HANSA MARKETPLACE HAS BEEN TAKEN DOWN!!!" https://www.youtube.com/watch?v=yqwwQ-jucl4 -~-~~-~~~-~~-~-
Просмотров: 1677 AVI
Rák - Az OrvosTudomány Hazugság (Part 4.)
Amennyiben Tetszett A Videó Kérlek Segíts Terjeszteni, Kattints A LIKE Gombra És Oszd Meg Ahol Csak Tudod! ------------------------------------------------------------------------------------------------------ INFO BUBBLE on FACEBOOK: https://www.facebook.com/infobubble YOUTUBE: https://www.youtube.com/channel/UCSGVfq4tilJlFpPufrMpwPw TWITTER: https://twitter.com/Info_Bubble ----------------------------------------------------------------------------------------------------- Amennyiben Esetleg Támogatni Szeretnéd A Munkánkat, PAYPAL-on Keresztül Egyszerűen Megteheted / In Case You'd Like To Support Our Efforts You Can Simply Do It Via PAYPAL: FURNACEOFIRON@GMAIL.COM ------------------------------------------------------------------------------------------------------ SHALOM ÉS HALLELUYAH! ------------------------------------------------------------------------------------------------------ Zsoltárok 40:3-5Hungarian Károli (KAR) 3 És kivont engem a pusztulás gödrébõl, a sáros fertõbõl, és sziklára állította fel lábamat, megerõsítvén lépteimet. 4 És új éneket adott szájamba, a mi Hatalmasságunak dicséretét; sokan látták és megfélemlettek, és bíztak YAHUAH ban. 5 Boldog ember az, a ki YAHUAH ba vetette bizodalmát, és nem fordul a kevélyekhez és a hazugságra vetemedettekhez! cancer  https://www.cancertutor.com/deathbydoctoring4/ https://www.cancertutor.com/chemospill/ WE ARE A PREMIER SOURCE FOR CANCER  STATISTICS IN THE UNITED STATES. https://seer.cancer.gov/ http://www.cancercenter.com/stomach-cancer/statistics/tab/stomach-cancer-survival-statistics/ http://onlinelibrary.wiley.com/doi/10.3322/caac.21149/full# https://www.cancer.gov/about-cancer/understanding/statistics http://www.who.int/mediacentre/factsheets/fs297/en/ http://www.cancer.ca/en/cancer-information/cancer-101/cancer-statistics-at-a-glance/?region=on Megdöbbentő magyar rákstatisztika: több esetben drámai romlás http://www.alon.hu/aktualis/2017/01/megdobbento-magyar-rakstatisztika-tobb-esetben-dramai-romlas http://oki.antsz.hu/documents/nekap_halalozas2.pdf A halálokokra vonatkozó statisztika http://ec.europa.eu/eurostat/statistics-explained/index.php/Causes_of_death_statistics/hu https://www.ncbi.nlm.nih.gov/pubmed/15630849 The Contribution of Cytotoxic Chemotherapy to 5-year Survival in Adult Malignancie https://www.burtongoldberg.com/home/burtongoldberg/contribution-of-chemotherapy-to-five-year-survival-rate-morgan.pdf Statistics and facts about the pharmaceutical industry worldwide https://www.statista.com/statistics/279916/top-10-therapeutic-classes-by-global-pharmaceutical-sales/ https://www.statista.com/topics/1764/global-pharmaceutical-industry/ https://www.statista.com/statistics/265940/leading-pharmaceutical-companies-by-prescription-sales-and-rundd-spending/ 2016 Global 2000: The World's Largest Drug And Biotech Companies http://www.forbes.com/sites/corinnejurney/2016/05/27/2016-global-2000-the-worlds-largest-drug-and-biotech-companies/#535263091d50 http://www.forbes.com/sites/steveschaefer/2016/05/25/the-worlds-largest-companies-2016/#39d3932637eb Egészséges életmóddal megelőzhető lenne a rák okozta elhalálozások fele http://delzalapress.hu/tag/rak-magyarorszag-statisztika/ http://www.canceractive.com/cancer-active-page-link.aspx?n=248 SHOCKING CANCER SURVIVAL RATES FROM NATURAL TREATMENTS : SPECIAL HEALING CANCER WEEK http://renegadehealth.com/blog/2012/03/26/shocking-cancer-survival-rates-from-natural-treatments
Просмотров: 2464 INFO BUBBLE
Global Generic Drug Market Size, Share, Price Trends, Forecast 2017-2022
To get more information, please visit @ http://www.imarcgroup.com/generic-drug-manufacturing-plant The global generic drugs market has witnessed a rapid growth in recent years. Some of the factors which have helped in the market growth of generic drugs are their performance characteristics, cost-effectiveness, reduced investments in R&D, patent expiry of the branded drugs, etc. Request sample of the report: http://www.imarcgroup.com/request?type=report&id=549&flag=B Find latest reports from Healthcare industry: http://www.imarcgroup.com/categories/healthcare-market-research-reports Contact Us IMARC Group USA: +1-631-791-1145 Email: sales@imarcgroup.com Website: http://www.imarcgroup.com Follow us on twitter: @imarcglobal
Просмотров: 19 IMARC Group
How Big Pharma Turned Pleasantville Into Zombieland
To learn more about this topic, visit http://www.levinlaw.com/america-lawyer Ring of Fire’s Mike Papantonio and Sam Seder discuss the corporate mentality of large pharmaceutical companies that calculate the cost of a human life, as just the cost of doing business. Ring of Fire needs your help! Support us by becoming a monthly patron on Patreon, and help keep progressive media alive!: https://www.patreon.com/TheRingofFire Spread the word! LIKE and SHARE this video or leave a comment to help direct attention to the stories that matter. And SUBSCRIBE to stay connected with Ring of Fire's video content! Watch America's Lawyer featuring Mike Papantonio on RT: https://www.rt.com/shows/americas-lawyer/ Order Mike Papantonio's novel Law and Disorder today: https://www.amazon.com/Law-Disorder-Mike-Papantonio/dp/1590793676 Follow more of our stories at http://www.TROFIRE.com Subscribe to our podcast: http://www.ROFPodcast.com Support Ring of Fire by subscribing to our YouTube channel: https://www.youtube.com/user/golefttv?sub_confirmation=1 Be sociable! Follow us on: Facebook: http://www.facebook.com/RingofFireRadio Twitter: http://www.twitter.com/RingofFireRadio Google+: http://plus.google.com/118415831573195648557 Instagram: https://www.instagram.com/ringoffirenetwork/
Просмотров: 2577 The Ring of Fire
Best Quality products| Pcd Pharmaceutical  franchise| Penlon
Business Oppurtunity with Best Pcd Pharma Franchise Company | Call us 9417936662 Penlon(India)Pharmaceuticals is Best Pcd Pharma franchise companies in Chandigarh and India.We are recognized in the market, due to our quality of products, Wide range of PCD Pharma Products and Sevices of our company. We have a qualitative range of pharmaceutical products for Pharma Pcd Franchise on Monopoly basis. We have a wide range of Tablets, Hard and soft Gelatin Capsules, Syrups, Dry syrups, Injections, Piadiatric , Cardio-Diabtic , Ointments, Dental , and Ayurvedic products. Penlon (India) Pharmaceuticals offer Business oppurtunity to all over India by giving the Pcd Phamra Franchise | Pharmaceuticals Distributors and New Business Start up individuals with Monopoly rights area wise. Penlon(India) Pharmaceuticals is an ISO 9001:2008 Company and all our products are GMP certified. We always use high quality of raw material to produced our producted and all raw materials are tested in Lab before taking a batches of Products. Our products design is unique and Drip off carton (which is a latest technology) are used in packing of our products. We are very dedicating in not only the quality of our products but as well as our services. We deliver the goods same day and material track by our staff daily and inform to our clients time to time til the material reached at destination. Pcd Pharmaceutical company, we offer a more than 200 Product range consisting of tablets, capsules, syrups, injections, protein supplements and Ayurvedic products, all approved by (DCGI) and WHO, GMP Certified . From raw materials to processed drugs, we always comply with the industry standards to deliver high quality, pure and effective products to the society. Our Products offer not only higher margins but also ensures quality with timely deliveries. We offer Pharma Pcd Franchise area wise to whole sale chemists, pharma distributors/ stockist, Medical Representatives/ Area Sales Manager/ Regional Sales Manager for ethical promotion of our quality product range. We have in our portfolio, a wide range of products, either different in formulations or having advance technology & having certain U.S.Ps. (Unique selling propositions) which keeps our brand above the mushrooms of many "ME Too's" in the market. To become a reputed Pharma Pcd Franchise Company in India in sphere of excellence and quality products and be the first choice of every customer by providing them value for money. If you are interested in operating as a franchise anywhere or in unrepresented India, then get in touch at the below mentioned contact numbers - +91-9417936662 for Franchise Opportunity/Pharma PCD/ Pharma Franchise/ Pharma PCD Franchise Penlon(India)Pharmaceuticals is headed by Mr. D.S.RAWAT who had rich experience of pharmaceutical industry at different level in management category in various reputed companies. There able guidance has propelled us to a prominent position in this highly competitive industry and their quality driven approach inspires us to provide our partner the best products in the market. Penlon (India)Pharmaceuticals is a ISO 9001-2008 Certified Chandigarh based pharmaceutical company having operation in all over India. Penlon(India)Pharmaceuticals is with a powerful combination of skills, resources and our support system that provides a platform for delivering strong growth in today's rapidly changing healthcare environment. pcd pharma companies indian pharma pcd companies pcd pharma companies healthcare medicine pharma pcd company pcd pharma companies in india pharma companies in chandigarh pcd pharma companies in chandigarh pharma franchise in chandigarh pcd pharma franchise in chandigarh pharma franchise company in chandigarh top pharma companies in chandigarh pharma manufacturing companies in chandigarh pharma franchise pharma franchise company pharma companies for franchise franchise pharma company in up pharma franchise in india pharma franchise companies in india pharma franchise opportunity pcd pharma franchise pharma pcd franchise pcd pharma franchise in india pcd pharma franchise monopoly basis top pcd pharma companies in chandigarh top pcd pharma companies in india pharmaceutical distributors www.penlonindia.com https://www.facebook.com/penlonindia/ https://twitter.com/PENLONINDIA https://plus.google.com/u/0/+PenlonindiaPharmaceuticals
Просмотров: 1077 Penlon PCD Pharma franchise india
HEROIN: The Doctors Time Bomb (OxyContin)
ADDICTS LIVES MATTER The Doctors Time Bomb (OxyContin) and how we got here. How Pharmaceutical sales reps lied, bribed and pushed OxyContin on to Doctors for profit. How they deliberately covered up and said it wasn't addictive. How they persuaded Doctors to continue prescribing OxyContin by buying their way into their pockets with money, gifts, expensive dinner and trips. It was touted as a miracle pill: a narcotic pain reliever that could change the lives of people suffering from chronic pain, but with little -- so its maker claimed, and thousands of doctors believed -- risk of addiction. Since OxyContin was introduced in 1996, Canada has recorded the second-highest number of prescription opioid painkiller addictions -- and the world's second-highest death rate from overdoses. "It's helping your pain, but then you get immune to it, so then you go to the family doctor and he says 'Well, you're gonna need more,'" a woman who became addicted to OxyContin tells the fifth estate's Linden MacIntyre. "So he puts you on the 40 milligram (dose) and you're on that for a month, and then you get used to that dose and he puts you on the 80s." But how did a little pill that only appeared in 1996 become so big, so fast? In 1998, Canadian sales were just a few million dollars. Twelve years later they had soared to $243 million. In the U.S., sales were $3.5 billion in 2010. Though there were differences in corporate style and legal structure between Purdue in the U.S and in Canada, a similar marketing approach proved wildly successful. the fifth estate examines why medical schools, GPs and specialists in pain clinics readily embraced the drug at first, and why some have now changed their minds. OxyContin was dropped from provincial health plans in Ontario, Saskatchewan and Atlantic Canada. The manufacturer has now stopped making it altogether, replacing it with a new formulation known as OxyNeo. But is it too little, too late? Did the drug's maker low-ball the risks? Did they know their time-release miracle pill was really a time bomb of addiction, waiting to go off? Original airdate : March 9th, 2012 For more on the fifth estate : http://www.cbc.ca/fifth Follow us on Twitter : http://www.twitter.com/cbcfifth Like us on Facebook : https://www.facebook.com/thefifthestate Category News & Politics License Standard YouTube License
Просмотров: 44639 AddictsLivesMatter
Make Way For Generic Drugs
Govt may start a legislation make it mandatory for doctors to write a generic name and not mention brand names on the prescription. Ekta Batra and Archana Shukla file this report.
Просмотров: 291 CNBC-TV18
Big Pharma Donates Millions To Congress
How did the pharmaceutical industry get Congress to relax oversight of opioid distribution? KDKA's Jon Delano reports.
Просмотров: 78 CBS Pittsburgh
City considers suing big pharma for opioid epidemic in Delray Beach
Hold big pharma accountable for opioid epidemic. Delray Beach's mayor is floating the idea of following the state of Ohio's lead.
Просмотров: 78 WPTV News | West Palm Beach Florida
Top High Salary Jobs after MBA
Top High Salary Jobs after MBA For detailed articles 1. High Paying Jobs and Career Choices after MBA visit: http://careersandmoney.com/high-paying-jobs-career-choices-after-mba/ 2. Commonly Business School Interview Questions with Answers for MBA Entrance http://careersandmoney.com/common-business-school-interview-questions-with-answers-for-mba-entrance/ Here is a link to playlist which has more than 8 videos giving individual questions and answers. Commonly Asked Business School Interview Questions and Answers for MBA Entrance https://www.youtube.com/playlist?list=PLSx9V0Bx_O_q54oQJ261GGe135Cisa7Sp Our Standard Video Making Gear (affiliate links): • Laptop: https://amzn.to/2GYTX8u • Microphone: https://amzn.to/2L1yXQS • Mobile Phone: https://amzn.to/2smb6Uo MORE USEFUL VIDEOS: • Commonly Asked Business School Interview Questions for MBA Entrance https://www.youtube.com/watch?v=XjTyUqPUTp4 o Tell me about yourself https://www.youtube.com/watch?v=wEImkTqM_Ag o Why do you want to earn a graduate business degree? https://www.youtube.com/watch?v=50rDD0AlOjk o Why are you interested in this school/program? https://www.youtube.com/watch?v=Hrwkb2MeZWw o Why should we admit you? https://www.youtube.com/watch?v=D9Geq15gWYk o Do you have a career goal? https://www.youtube.com/watch?v=-vAGSNCBGxY o What qualities should a successful manager have? https://www.youtube.com/watch?v=Nk8OZGL8q-A o Talk about your accomplishments as a leader. https://www.youtube.com/watch?v=tnnWzcKgv-Y o What are your Strengths and Weaknesses? https://www.youtube.com/watch?v=Q-L2RD8tf5g • Commonly Asked Business School Interview Questions for MBA Entrance https://www.youtube.com/watch?v=XjTyUqPUTp4 • Common Bank Interview Questions and Answers https://www.youtube.com/watch?v=e0g8mDzi6Y4&t=123s • Sales Job Interview Questions and Answers https://www.youtube.com/watch?v=Y5F42ECHCxk • Important Job Interview Questions for Fresh Graduates https://www.youtube.com/watch?v=QVH9rs8W8l4 • Entry level interview questions for Accounts, Accounting, Finance Jobs https://www.youtube.com/watch?v=Kone-glRdRI • Entry Level Job Interview Questions and Answers for Engineers https://www.youtube.com/watch?v=pGHrJYGcD0s&t=20s • Tricky Brainteaser Job Interview Questions https://www.youtube.com/watch?v=Z79dqDLH_Qw FOR CAREER DEVELOPMENT SERVICES: • Interview Training: http://careersandmoney.com/interview-coaching/ • Career Counseling: http://careersandmoney.com/career-counselling/ • Executive Coaching: http://careersandmoney.com/executive-coaching/ • CV Making: http://careersandmoney.com/cv-writing-services/ Social Media Links • https://www.facebook.com/cvmaking • https://twitter.com/careersmoney Other useful links • http://www.cvmaking.com • http://acsjobs.in/content/page/corporate-training.php • http://cvmaking.com/modules/cms/about-the-ceo.php Do like | Do share and post your views. More videos coming soon. All the best ! wish you all the success careersandmoney Sundeep Kataria Since 1997 CVMAKING.COM -- a division of ACS CONSULTANTS offers dedicated: • Interview Coaching • Career Counseling • Executive Coaching • Personality Development • Professional CV Writing • Cover Letter Writing • CV Evaluation • Resume Flash Services to candidates all across India as well as many other English speaking countries. For more details of our services, click http://cvmaking.com/ or http://careersandmoney.com/ or contact us at cvmaking.com@gmail.com ABOUT SUNDEEP KATARIA Professionally he is a Management Consultant, Corporate Trainer, Motivational Speaker, Life Coach, Content Writer, Corporate Trainer & Author. Sundeep Kataria is highly educated and professionally qualified - MBA, Post Graduate Diploma in International Trade from Indian Institute of Foreign Trade (one of the top 10 B Schools in India). He has authored 4 books besides regularly writing many blogs and articles. CONTACT US FOR CONDUCTING OPEN WORKSHOPS AND IN -- HOUSE TRAINING PROGRAMS FOR A UNIQUE EXPERIENCE. Keep practicing with this video often, to sustain the benefits. Contact: Phone : (+91-11) 43022692, 43022693, 9873372726 Image Credit: FreeDigitalPhotos.net and Pixabay.com
Просмотров: 146650 Careers and Money
Glenmark Pharmaceuticals : Interview Questions and Useful Tips.
This interview will not just throw light on Glenmark Pharmaceuticals recruitment procedure but will also give you loads of useful tips.
Просмотров: 17812 Zubeen Lapsiwala
Doctors Make Big Money Selling You Pills: Corporations Pay The Bonuses
Via America’s Lawyer: Mike Papantonio and Attorney Dan Soloway talk about how the last prescription your Dr. gave you was probably the result of pharmaceutical kickbacks in cash. To learn more about this topic, visit http://www.levinlaw.com/america-lawyer Ring of Fire needs your help! Support us by becoming a monthly patron on Patreon, and help keep progressive media alive!: https://www.patreon.com/TheRingofFire Spread the word! LIKE and SHARE this video or leave a comment to help direct attention to the stories that matter. And SUBSCRIBE to stay connected with Ring of Fire's video content! Watch America's Lawyer featuring Mike Papantonio on RT: https://www.rt.com/shows/americas-lawyer/ Order Mike Papantonio's novel Law and Vengeance today: https://www.amazon.com/Law-Vengeance-Mike-Papantonio/dp/1590794362 Follow more of our stories at http://www.TROFIRE.com Subscribe to our podcast: http://www.ROFPodcast.com Support Ring of Fire by subscribing to our YouTube channel: https://www.youtube.com/user/golefttv?sub_confirmation=1 Be sociable! Follow us on: Facebook: http://www.facebook.com/RingofFireRadio Twitter: http://www.twitter.com/RingofFireRadio Google+: http://plus.google.com/118415831573195648557 Instagram: https://www.instagram.com/ringoffirenetwork/
Просмотров: 1446 The Ring of Fire
Nigeria's Dangerous Street Drug Epidemic
Nigeria has a new, dangerous drug problem as cheap drugs, like codeine and morphine, threaten the country's youth. BattaBox Presenter, Warri Pikin hits the streets of Lagos to find out. ► Subscribe to BattaBox on YouTube: http://goo.gl/4dgy2r "The reason I take codeine is because of the inspiration I take from it - I'm an artist, I get inspiration for my music, I go on a trip and feel on cloud nine," explains a young Nigerian drug abuser. Codeine is often found in cough medicine from local pharmacies, and they drug users then mix it with coke or other soda drinks for sweetness, called "Purple Drank" in American slang. The sweet taste allows the abuser to drink more. Codeine (otherwise known as "Blunts" on the streets of Lagos), morphine, Refnol, and Tramadol belong to a class of drugs called Opiods, which are traditionally used to manage pain, but the drugs also have serious addictive qualties and are used by young men on the streets of Lagos to get high. In fact, codeine has been classified as a Schedule II drug, meaning it has a "high potential for abuse." "I prefer codeine and smoking, I like to be on my own, it makes me feel calm," says one young Nigerian man, who does not give his name. "The way Nigeria is now, people don't like drinking beer, because if you drink too much alcohol, you will end up in the gutter. But with codeine, anywhere you take it, you will get to your house," explains one Nigerian youth who takes codeine. The short-term effects include euphoria and altered consciousness, but long-term abuse can result in seizures, organ damage, and even death. And Nigeria has a devastating problem with codeine sweeping the country. Nigeria's Senate recently announced an addiction epidemic across the north, with an estimated 3 million bottles of codeine consumed across daily in major cities. In particular, girls in school, women displaced by Boko Haram, or just working women have become addicts, consuming up to ten bottles of cough syrup a day. According to the National Drug Law Enforcement Agency, NDLEA, 2015 annual report - Nigeria's North west had the most arrests for drug related offences. A total of 2,205 persons were arrested in the North West, and 1,785 arrests recorded in the South West where we put together our report for BattaBox. Nigeria's Senate President, Bukola Saraki, announced on Twitter: "I am particularly worried about the drug menace in the Northern part of the country. It is the time that we recognize this problem and address it in a sensible manner. I will be pushing for the National Assembly to review all relevant laws on drug abuse. This will help to curb the widespread misuse of illegal and unsanitary substances. The Senate will engage with all relevant stakeholders as we initiate this process." It is a problem that has reached even into Nigeria's entertainment industry, with Nollywood actresses such as Toyin Aimakhu admitting to drug abuse. "I was losing touch with things that used to work for me because I was involved with negative habits like drugs, smoking, codeine. Codeine is very bad, it's very bad. All these things were empowering my negative energy," Toyin Aimakhu, star of "Love is in the Hair", admitted. Nigeria is often regarded as a transit point for drugs into Europe and America, but increasingly has a domestic drug problem. The country's National Drug Law Enforcement Agency (NDLEA) makes regular arrests and drug seizures - waging a war on drugs, but the battle is far from over, and now spilling into the streets. "I started taking drugs in Nigeria when something went down between me and my old man," explains the Lagos youth. "A friend of mine was taking codeine and I asked to have a taste." The problem for Nigeria's Drug authorities is that the pharmaceuticals are not illegal. And no one at the "Ghetto Republic 1759" is worried about being arrested: "We buy it at the pharmacy, and on the condition of Nigeria like this, nobody asks why you buy it," says the young Lagos guy. "We never have any issues with any police." What do you think about the drugs problem in Nigeria? Gist us in the comments below. **** CLICK HERE TO SUBSCRIBE FOR NEW BATTABOX VIDEOS EVERYDAY: https://battabox.com/subscribe/ YOU can support BattaBox here: http://www.patreon.com/BattaBox ... Website: https://BattaBox.com ... YouTube: https://www.youtube.com/user/BattaBox ... Facebook: https://www.facebook.com/BattaBox ... Twitter: https://twitter.com/BattaBoxNigeria ... Google+: https://www.google.com/+BattaBox ... Instagram: https://www.instagram.com/BattaBox **** BattaBox is the most exciting Nigerian News & Entertainment Video channel based in Lagos. We are the fact behind Nigerian Movies fiction, Nollywood in real-life with a dash of Yoruba Movie Magic - but none of our videos are made-up like Nollywood - they are all true stories! BattaBox is Nigeria Like You've Never Seen Before!
Просмотров: 54692 BattaBox
What Kind Of Drug Is Seroquel
It is also sometimes used as a sleep aid due to its sedating effect, but this use not recommended. Nami national alliance on mental illness. Quetiapine oral tablet drug information, side effects, faqs cvs. Common side effects include jul 15, 2017 quetiapine is not approved by the food and drug administration (fda) you your doctor will decide what type of treatment right for medscape schizophrenia, bipolar disorder specific dosing seroquel, seroquel xr brand other names class belongs to a medications known as antipsychotics. Seroquel oral uses, side effects, interactions, pictures, warnings webmd drugs 2 drug 4718 seroquel details url? Q webcache. Tell your medication class second generation antipsychotic (sga), atypical avoid drinking alcohol or using illegal drugs while you are taking quetiapine nov 27, 2013 the drug is designed to treat schizophrenia and bipolar disorder, but year, seroquel was fifth largest selling pharmaceutical of any kind, oral tableton this page frequently asked questions related by cvs patient statistics learn more. Growing concerns over side effects of psychiatric drug seroquel abc. Seroquel oral uses, side effects, interactions, pictures, warnings seroquel (quetiapine fumarate) warning drug dosage & effects drugs (quetiapine) basics, reviews iodine dosage, interactions. Quetiapine side effects, uses, dosage, overdose, pregnancy. This medication is used to treat certain mental mood conditions (such as schizophrenia, bipolar disorder, sudden episodes of mania or depression associated with disorder). Seroquel is used to treat schizophrenia in adults read this medication guide before you start taking seroquel and each time get a refill. Jul 7, 2015 quetiapine get up to date information on side effects, uses, dosage, overdose, pregnancy, is part of the drug class. It is taken by mouth seroquel belongs to of medications called atypical antipsychotics. There may seroquel is a prescription medicine used to treat (quetiapine) has moderate high risk of weight gain, elevated cholesterol drug class mental healthgeneric status quetiapine, marketed as among others, an atypical antipsychotic for the treatment schizophrenia, bipolar disorder, and major depressive disorder. Googleusercontent search. Seroquel oral uses, side effects, interactions, pictures, warnings. Seroquel (quetiapine) dosage, indication, interactions, side seroquel (quetiapine fumarate) dose, indications, adverse effects seroquel, xr drug effects, interactions 25 mg, 100 200 300 mg film coated tablets emc. Seroquel, xr, quetiapine side effects (weight gain), dosage & abuseseroquel, seroquel xr (quetiapine) dosing, indications, interactions uses, effects, medbroadcast. Quetiapine (seroquel). The food and drug administration (fda) approved quetiapine in 1997 under the nov 4, 2016 seroquel xr (quetiapine) is an antipsychotic used to treat bipolar disorder schizophrenia. It works by changing the actions of chemicals in brain. Suggested this medication for conditions oth
Просмотров: 200 Green Help
Lousy Stocks Are Rallying. Beware the Value Traps!
Subscribe to stay up to date with the latest videos ► https://www.sbry.co/YTNeW NewsWire Market Watch – Lousy Stocks Are Rallying. Beware the Value Traps! ↓↓↓↓↓↓↓↓↓↓↓↓ STORIES AND MORE BELOW ↓↓↓↓↓↓↓↓↓↓↓↓ Download the NewsWire app for more expert market updates throughout the day: GOOGLE PLAY APP ► https://www.sbry.co/NOgkj APPLE ITUNES APP ► https://www.sbry.co/z8IIy Check out NewsWire’s Investors MarketCast ↓ GOOGLE PLAY MUSIC ► https://www.sbry.co/dzzKq APPLE ITUNES ► https://www.sbry.co/GoCV0 ———————————— Follow us on Twitter ► https://www.sbry.co/cIZHu Join our Facebook Community ► https://www.sbry.co/cadxP Check out our website ► https://www.sbry.co/CcszZ Check out Health and Wealth Bulletin ► https://www.sbry.co/NwRmD Check out Stansberry Investor Hour ► https://www.sbry.co/NeWIh Check out Extreme Value ► http://www.sbry.co/NwEvI ———————————— CALENDAR: Nikkei Japan Services, Composite PMI for September France Markit Final Services, Composite PMI for September (3:50am) Germany Markit Final Services, Composite PMI for September (3:55am) Eurozone Markit Final Services, Composite PMI for September (4am) Eurozone Retail Sales for August (5am) MBA Mortgage Applications (7am) ADP Employment Change (8:15am) Markit Final Services, Composite PMI for September (9:45am) ISM Non-Manufacturing Composite for September (10am) Energy Information Administration Crude Oil Inventory Data (10:30am) Fed’s Yellen Speaks (3:15pm) ———————————— MARKET HEADLINES: Trump's aides deliver their shortlist of candidates to lead the Federal Reserve, sources say ► https://www.bloomberg.com/news/articles/2017-10-04/trump-aides-are-said-to-deliver-shortlist-of-fed-candidates Two Wall Street giants criticize Trump tax plan ► https://reut.rs/2xQ2Kq8 Fed chair hopeful draws opposition from the left and the right ► https://www.bloomberg.com/news/articles/2017-10-04/fed-chair-hopeful-warsh-draws-opposition-from-left-and-right Spain’s king says Catalan leaders have ‘undermined harmony’ as protests swell in region ► https://www.wsj.com/articles/catalan-separatists-take-to-streets-to-protest-spanish-police-1507028333 Japan September services PMI shows growth slowest in 11 months ► https://reut.rs/2fI0g57 Republicans Are Reconsidering Full Repeal of State and Local Tax Deduction ► https://nyti.ms/2xS1a7e Trump suggests Puerto Rico's debt may need to be "wiped out" ► https://www.bloomberg.com/news/articles/2017-10-04/trump-suggests-puerto-rico-s-debt-may-need-to-be-wiped-out White House to request $29 billion for hurricane relief ► https://reut.rs/2fJWxE0 U.S. Missile Defense Gets $400 Million After North Korea Threats ► https://www.bloomberg.com/news/articles/2017-10-03/u-s-missile-defense-gets-400-million-as-north-korea-threatens . Yahoo triples estimate of breached accounts to 3 billion ► https://www.wsj.com/articles/yahoo-triples-estimate-of-breached-accounts-to-3-billion-1507062804 Amazon Hit With $294 Million Bill in EU Tax Crackdown ► https://www.bloomberg.com/news/articles/2017-10-04/amazon-hit-with-294-million-bill-amid-renewed-eu-tax-crackdown Mylan surges as its generic of Teva's Copaxone gets FDA nod ► https://reut.rs/2fL96yU Ford to focus on high-growth areas, cost cutting ► https://www.wsj.com/articles/ford-to-focus-on-high-growth-areas-cost-cutting-1507064473 Hurricane recovery helps boost U.S. September new auto sales ► https://reut.rs/2fGss8c
Просмотров: 228 Stansberry NewsWire
Opioid Addiction Treatment and Litigation
Good afternoon, everyone. I hope you all had a great weekend. It’s always fun to come back to work on a Monday. I find that, as much as I try to relax on the weekends, the nature of our business doesn’t allow for that. I never complain because it’s a labor of love to help people. I want to address a couple of comments that were made with regards to my last video. It had to do with the fact that, of the $54 million that’s coming into the state of Florida as a result of the state of emergency declared by the governor, apparently, we’re only getting $400,000 here in Palm Beach County. Of that money, it’s apparently being used for medically assisted treatment. I got a little blow back from folks who said, “There’s evidence that this stuff works.” I’m no therapist. I’m not a scientist. I only know what I see in my practice. What I see is individuals from the ages of 18 to 30 who are addicted to drugs as a result of opioids that have been prescribed to them by doctors who are pushed, prodded and incentivized by pharmaceutical companies. They give kids opioids when they probably don’t need them. That’s what irritates me. The fact that we’re going to give more money to the pharmaceutical companies to fix a problem that they, in large part, caused rubs me the wrong way. Statistics or no statistics. I have a problem with that. If we can use some type of medically assisted treatment to get people off drugs and ultimately into some type of abstinence based treatment, I’m all for that conversation. If you’re going to tell me that we’re going to take one opioid and swap it in for another one, I have a problem with that. I think a lot of other people do, too. There was an interesting 60 Minutes piece on the TV last night. It was a follow up to the 60 Minutes piece they had done a couple of weeks ago that talked about the fact that our federal government has wimped out when it comes to going after the big pharmaceutical companies that are peddling these drugs to our kids and whoever else is being prescribed them. The first show talked about the fact that the DEA has had their hands tied. Yesterday’s show talked about the fact that they haven’t had the stones to take these guys to court. One of the companies they specifically talked about was McKesson. I don’t have a problem talking about it because the whole country heard about McKesson last night. They made about $200 billion last year as a result of selling pharmaceuticals. They got a whopping $150 million fine. I haven’t done the math, but I bet it doesn’t take a lot of time for them to make $150 million. Seeing as how no one is going to jail, being indicted or prosecuted, I don’t suppose they care much about the fact that they’re getting a slap on the wrist. My practice is focused on helping individuals in crisis because of addiction and mental illness. I lay a large part of that blame on the fact that we as a society have had these drugs rammed down our throats. One of the reasons that I got involved in the opioid litigation is to help families that have suffered, whose kids have overdosed, and have lost kids as a result of this. I don’t apologize for that. If you know anyone who has a child who was prescribed an opioid and has since overdosed, or worse, has died, I want you to give us a call. Ask to speak to the opioid litigation team. We can help people. The only way to fight back is to punish the pharmaceutical companies. I know that money doesn’t bring a loved one back, but it gets a little justice for the family. That’s ultimately what it’s all about. I always appreciate the comments. I love the comments that challenge me intellectually. For the folks who post things on Facebook disagreeing with what I said, keep it coming. I always enjoy an intellectual conversation. If you know a family that is in crisis and needs help, have them give us a call. Thank you.
Просмотров: 25 Drug And Alcohol Attorneys
Amazon’s Pharmacy – What Effect will it have on Indian Generic Producers?
The e-commerce giant Amazon has reportedly set a November deadline to decide on whether it will move into the drug supply chain market or not. Should Amazon decide to make a move, the company could help to dramatically drive down the cost of drug prices. Click here to read full analysis: https://goo.gl/aBRFF3
Просмотров: 20 Ketan Verma
Stocks Helpline: Expert advises to hold Glenmark Ph as it can bring better return in future
This segment of Stocks Helpline brings to you market experts' views on your stocks. Confused where to trade? Watch full video to know more. About Zee Business -------------------------- Zee Business is one of the leading and fastest growing Hindi business news channels in India. Live coverage of Indian markets - Sensex & Nifty -------------------------------------------------------------- You can also visit us at: https://goo.gl/sXWpTF Like us on Facebook: https://goo.gl/OMJgrn Follow us on Twitter: https://goo.gl/OjOzpB Subscribe to our other network channels: Zee News: https://goo.gl/XBvkjZ
Просмотров: 870 ZeeBusiness
Pharmacy Benefit Managers: Companies In The Thick Of Prescription Drug Pricing
For the past seven months, the GOP push to replace the Affordable Care Act has consumed Washington. All the while, many consumers continue to be focused on the rising costs of prescription drugs. Pharmacy benefit managers — companies that are often unnoticed and even less understood by most consumers — hold an important place in the prescription drug-pricing pipeline. In this video, Kaiser Health News details the emergence of these multimillion-dollar corporations and the impact they have on medication costs and patients’ access to these treatments.
Просмотров: 5488 Kaiser Health News
BTC News - Not Just Drugs: Darknet Markets Carry a Variety of Goods for Your Bitcoin
Not Just Drugs: Darknet Markets Carry a Variety of Goods for Your BitcoinSince the fall of the darknet markets Hansa and Alpha Bay, three markets have taken the reigns on the deep web. Now Dream, Point Marketplace, and the Wall Street Market are the top darknet markets, and since they took over, there's a variety of different kind of vices other than drugs. Also read:  New Market Leaders Carry All Kinds of Goods and Services Currently, the top three darknet marketplaces are doing well for themselves as they have replaced the fallen soldiers selling their wares on the deep web. Without adding vendor shops, there are roughly eight very large darknet marketplaces (DNM) on the web which include , the Wall Street Market (WSM), the Majestic Garden, CGMC, Point Marketplace, Zion Market, Berlusconi Market, and the monero-only Libertas Market which is currently offline. Typically when people think of DNMs, the first thing that comes to mind is the buying and selling of illegal narcotics. However, the top three DNMs Dream, Point, and WSM cater to a lot of different goods unlikeand Hansa’s former halls of chemicals. Streaming Movies and a Whole New Identity In fact, for a little bitcoin, there's a lot of other types of goods (most of which are still illegal) besides drugs that can be purchased on DNMs. For instance, on the WSM and other markets, users can buy a vast array of digital goods. This includes pirated software, , unreleased movies, books, and music. Stolen accounts to streaming video sites like Netflix, as well as Apple ID accounts for iTunes, and lifted Gmail accounts for Google Play. If these free accounts are not enough, DNM visitors can also purchase stolen gift cards, credit card credentials, passports, and social security numbers of the deceased. From anywhere to $25-100, a student can get a term paper written for them. Or maybe a thrifty shopper wants to save a few bucks by purchasing some counterfeit coupons which are regularly for sale in both physical and digital form on many DNMs. Further, there are people traveling all around the world using lifted Uber and Lyft accounts as well. And instead of buying that college term paper why not skip the entire curriculum altogether and get a fake college degree? Anyone paying anywhere from $1,000-5,000 worth of BTC can obtain a counterfeit degree from Harvard, Yale, MIT, and many other well-known universities.Sex and Hacks People who are into fetishes and kinky sex goods and services will also enjoy the deep web market's offerings. There are many personalized sexual items that can be purchased like a pair of underwear or a bra worn by a famous actress. And just like the psychedelics and cannabis vendors, there are also vendors peddling Viagra, and pharmaceutical lotions and oils for those private parts. There are also hard to get videos and photographs of celebrities doingon camera. Marketplaces also carry great toys for hackers such as , stolen government intel, and loads of customer Not Just Drugs: Darknet Markets Carry a Variety of Goods for Your Bitcoin BTC News is the world's premier 24/7 news feed covering everything bitcoin-related. ‎About Bitcoin News, How to Calculate Bitcoin ... · ‎Bitcoin for Beginners ‎Op-Ed
Просмотров: 1875 Bitcoin News
R&D: "Frontiers of the Future" 1937 National Industrial Council; Lowell Thomas
Technology Miscellany playlist: https://www.youtube.com/playlist?list=PL1A5AECE797B4D332 more at http://quickfound.net/ "Produced to convince Depression-weary Americans that new frontiers still lay ahead. Excellent compilation of stock shots of 1930s-era manufacturing, research laboratories and industry." Produced by Audio Productions. Reupload of a previously uploaded film with improved video & sound. Public domain film from the Library of Congress Prelinger Archives, slightly cropped to remove uneven edges, with the aspect ratio corrected, and one-pass brightness-contrast-color correction & mild video noise reduction applied. The soundtrack was also processed with volume normalization, noise reduction, clipping reduction, and/or equalization (the resulting sound, though not perfect, is far less noisy than the original). http://creativecommons.org/licenses/by-sa/3.0/ http://en.wikipedia.org/wiki/Research_and_development The term R&D or research and development (or RnD especially in domain names; or Research and Technical Development; or Research and Technological Development or RTD in Europe) refers to a specific group of activities within a business. The activities that are classified as R&D differ from company to company, but there are two primary models. In one model, the primary function of an R&D group is to develop new products; in the other model, the primary function of an R&D group is to discover and create new knowledge about scientific and technological topics for the purpose of uncovering and enabling development of valuable new products, processes, and services. Under both models, R&D differs from the vast majority of a company's activities which are intended to yield nearly immediate profit or immediate improvements in operations and involve little uncertainty as to the return on investment (ROI). The first model of R&D is generally staffed by engineers while the second model may be staffed with industrial scientists. R&D activities are carried out by corporate or governmental entities... Background New product design and development is more often than not a crucial factor in the survival of a company. In an industry that is changing fast, firms must continually revise their design and range of products. This is necessary due to continuous technology change and development as well as other competitors and the changing preference of customers. Without an R&D program, a firm must rely on strategic alliances, acquisitions, and networks to tap into the innovations of others... In general, R&D activities are conducted by specialized units or centers belonging to a company, or can be out-sourced to a contract research organization, universities, or state agencies. In the context of commerce, "research and development" normally refers to future-oriented, longer-term activities in science or technology, using similar techniques to scientific research but directed toward desired outcomes and with broad forecasts of commercial yield. Statistics on organizations devoted to "R&D" may express the state of an industry, the degree of competition or the lure of progress. Some common measures include: budgets, numbers of patents or on rates of peer-reviewed publications. Bank ratios are one of the best measures, because they are continuously maintained, public and reflect risk. In the U.S., a typical ratio of research and development for an industrial company is about 3.5% of revenues. A high technology company such as a computer manufacturer might spend 7%. Although Allergan (a biotech company) tops the spending table with 43.4% investment, anything over 15% is remarkable and usually gains a reputation for being a high technology company. Companies in this category include pharmaceutical companies such as Merck & Co. (14.1%) or Novartis (15.1%), and engineering companies like Ericsson (24.9%).[1] Such companies are often seen as credit risks because their spending ratios are so unusual. Generally such firms prosper only in markets whose customers have extreme needs, such as medicine, scientific instruments, safety-critical mechanisms (aircraft) or high technology military armaments. The extreme needs justify the high risk of failure and consequently high gross margins from 60% to 90% of revenues. That is, gross profits will be as much as 90% of the sales cost, with manufacturing costing only 10% of the product price, because so many individual projects yield no exploitable product. Most industrial companies get only 40% revenues. On a technical level, high tech organizations explore ways to re-purpose and repackage advanced technologies as a way of amortizing the high overhead. They often reuse advanced manufacturing processes, expensive safety certifications, specialized embedded software, computer-aided design software, electronic designs and mechanical subsystems. Research has shown that firms with a persistent R&D strategy outperform those with an irregular or no R&D investment programme...
Просмотров: 2111 Jeff Quitney
Information Management Roles in Pharmaceutical Companies
Podcast Link: Abstract: You don’t have to be a STEM person to land jobs in the pharmaceutical industry. In fact, pharma companies are looking for a range of LIS skills, ones you can master in your iSchool program. Mindy Beattie, associate director of library & information services at Gilead Sciences, will share how the pharma industry lays out, various roles for information professionals in pharma organizations, skills in demand, and how to get started in an LIS pharma career. Biography: Mindy Beattie leads the Library & Information Services (LIS) group at Gilead Sciences, Inc. in Foster City, CA. The LIS group supports Gilead users globally with research services and access to databases and journals to enable all colleagues to make informed decisions. Before joining Gilead, Beattie managed teams at two pharmaceutical companies and a chemical company. Beattie holds a MSLS from Catholic University of America and a BA in Library Science and Sociology.
Просмотров: 241 SJSU School of Information
Comcast: Innovation and Digital Transformation CXOTalk #267
How are cable providers evolving to compete with cord-cutting, streaming services and new media? Chris Satchell, Executive Vice President and Chief Product Officer at Comcast Cable, speaks with CXOTalk and guest co-host Brian Solis about digital transformation in the cable TV industry. For more information: https://www.cxotalk.com/episode/comcast-digital-transformation-innovation Chris talks about using agile development for product devopment at Comcast, Xfinity, and the X1 platform. Satchell leads Comcast’s product, design and innovation teams in Philadelphia, Denver and Silicon Valley to develop and design the company’s consumer products used by millions daily. He previously served as Consumer Technology Officer at Nike, and EVP of research and development at IGT (International Game Technology), the world leader in gaming entertainment and casino systems. From the transcript: Chris Satchell: Well, the first thing I'll say is I think we did less continuous delivery 50 years ago than we do now. That seems likely a little bit before my time, but I fully agree with Brian. Brian and I, one of the reasons that we became friends is we see eye-to-eye on so many things about the consumer journey and how you have to enable that. I fully agree. Culture and people are the keys of any technology transformation, I mean any transformation, but especially technology transformations. One of the things I always think about, and I talk to people about this, is in my whole career I've only actually ever seen two projects go off the rails because of sheer technology, and your technology is just too hard to overcome. I mean it's just limitations at that point in history where you just couldn't get past it. Every other issue has been about people, and so, for me, technology is inherently a people issue. That's how we approach it. You have to get the culture right. You have to get the context right. You have to get the team right. You have to get direction right. Then you can drive change and accelerate it. You have to get the right platform. As we talk about enabling change, enabling innovation, it's fine to have great intentions. But, all your platforms, systems, the connectivity between them, and the tools you have to get ideas into those platforms, if they aren't in place and if they aren't designed around velocity, you're not going to be as fast as you need to be in this world. Although you have to have everything else, what I say about it is that a great team will overcome anything. If you can take a great team, give them the context including the tools to do great work, they will accelerate, and they will outstrip anything you thought they might be able to do. I'll tell you that, in many cases, I found that change agents have found that not only does ROI stand for return on investment; it also stands for return on ignorance. What happens if we don't do this? Brian Solis: What is that cost? What can we prove out that shows that these investments will yield this now and over time? It's really trying to change people's perspectives and mindsets of what return actually looks like. It opens their mind because, in many cases, executives don't know what they don't know. I want to believe that Chris is right that people want to do the right thing, that they're not evil in many ways. The reality is that many executives actually just don't live the life the way or live the company the way that their customers and employees do. I used to call this the Undercover Boss moment, if you ever watch that show, which [laughter] I love because it's always inspiring, but it has the same ending every episode. That is, when you put an executive in the shoes of an employee or a customer, they can't help but feel the empathy of what someone else has to go through on a day-to-day basis. It opens their eyes to see what's possible. We have right now such a distinct difference between how customers are evolving and employees are evolving and how executives are going day-to-day in terms of what they're reporting and what they're driving. Someone has to bridge that gap. Part of what Chris was referring to in terms of speaking the language or the common language, or what I call speaking the language of the C-suite, is that you have to put those numbers together. You have to be many things. I say in this research report on The Change Agent's Manifesto is that you have to be not just a politician, but also a lawyer and also a data storyteller in that you have to bring all of these different things together that show what someone needs to hear and how they need to hear it tied together with numbers, tied together with evidence, tied together with possible outcomes and potential outcomes so that everybody involved can believe in your work.
Просмотров: 7280 CXOTALK
FDA cracks down on supplements
For almost 5 years, the FDA has been attacking Daniel Smith of Spokane Washington for selling a mineral supplement that purifies water and has been used in places like Africa by the Red Cross to prevent Malaria. The product is called MMS (Miracle Mineral Solution), and the active ingredient is sodium chlorite, a common mineral that is even used in some municipalities in the U.S. to purify water instead of chlorine. Daniel Smith will face a trial in less than 30 days, the culmination of close to 5 years of legal battles, that could result in him spending 37 years in prison if convicted. Why? Because the FDA has not approved his product for health claims. Has the product killed anyone? No. Do FDA approved products kill anyone? Yes. According to statistics published by medical authorities themselves, FDA prescription drugs are one of the top causes of death in the United States, and probably the #1 cause of death among Americans today. An older study published by the Journal of the American Medical Association in 1998 stated that 106,000 people died from prescription drugs every year, and the CDC has previously stated that overdoses of FDA-approved prescription opioid pain relievers now exceed deaths involving heroin and cocaine combined. By contrast, a Government Accounting Office (GAO) report in 2013 found ZERO deaths due to dietary supplements. Most of the American public is probably largely unaware that the FDA’s mission is NOT to protect American’s health, but to approve pharmaceutical drugs. Most of its funding comes from the pharmaceutical industry itself, in the drug approval process. The cost to get a drug approved by the FDA is in the hundreds of millions of dollars. The revolving door policy between government health officials and pharmaceutical company executives has been well documented. There are only a handful of pharmaceutical companies that ever get drugs approved in the U.S. market, and if one were to develop a novel cure or drug outside of one of these handful of companies, the only hope they would have to get their product to market would be to sell their business and/or patent to one of these companies the FDA works with. - See more at: http://healthimpactnews.com/2015/fda-attacks-man-for-selling-supplement-that-has-healed-tens-of-thousands-facing-37-years-in-prison/#sthash.nLRBoVpH.dpuf -~-~~-~~~-~~-~- Please watch: "Hillary Uses Dallas Tragedy As a Decoy" https://www.youtube.com/watch?v=dfF1SmplWYY -~-~~-~~~-~~-~-
Просмотров: 14 Open Mind
Little Boy Blue
Over 11 million American children took antidepressant drugs in 2003. And the numbers are growing quickly-particularly among children aged five and younger. Little Boy Blue blends startling statistics with expert testimony, a mock public service announcement and words-from-the-mouths-of-babes to deliver a message that is a hard pill to swallow. University of Victoria drug-policy researcher Alan Cassels asserts “the [pharmaceutical] industry is in basically two businesses-the business of creating chemicals and the business of creating disease.” He examines the manipulative advertising techniques employed by drug companies and points out that they spend more money educating doctors about drugs than all medical schools in Canada combined. He also highlights the research of Dr. Andrew Mosholder, a senior epidemiologist at the U.S. Food and Drug Administration. In 2003, Mosholder found that children given antidepressants were nearly twice as likely to become suicidal. Ultimately, this cautionary documentary challenges parents to arm themselves with questions before putting their children in the hands of “experts.” Written, directed and produced by Donna Barker. (C) 2004 Study Guide available: http://www.donnabarker.com/meet-donna/littleboybluedocumentary/
Просмотров: 35 Donna Barker
60 Minutes Ex-Dea Agent on Opioid Crisis Reaction and Review
The recent 60 Minutes Ex-Dea Agent on Opioid Crisis episode was absolutely mind-blowing, and this is my reaction and review as an addiction advocate and professional. ______________________________________________________ Need to talk about your addiction, anxiety, depression or any mental illness? Chat with a licensed professional therapist online, use the link to start your journey NOW https://tryonlinetherapy.com/rewiredsoul This is an affordable online therapy website where you can choose what therapist you talk to depending on your problems. It's unlike any other therapy as YOU can decide what time you have your sessions, how you have them, where you have them and it's more affordable than your typical therapist! By using this referral link, you support the channel! _______________________________________________________________ Many people don't realize that the pharmaceutical industry and opioid crisis go hand-in-hand. Many people believe the heroin epidemic only affects those making bad decisions, but a lot of it stemmed from the pharmaceutical industry and opioid epidemic. Joe Rannazzisi was a DEA Agent trying to stop the United States opioid crisis from progressing, but congress as well as many others stopped him from letting this happen. He and his team were trying to pass United States drug laws to keep pharmaceutical distributors in check. In the clips you can see how the West Virginia opioid crisis was able to spiral out of control. In October of 2016, Last Week Tonight with John Oliver shed some light on opioids and the United States opioid epidemic, and now we're seeing that not much is being done. We need to come together and stop this to prevent more people from dying. Ex-DEA agent: Opioid crisis fueled by drug industry and Congress episode: Ex-DEA agent: Opioid crisis fueled by drug industry and Congress Watch the John Oliver Opioid Crisis video here: https://www.youtube.com/watch?v=5pdPrQFjo2o Follow me on social media: http://facebook.com/TheRewireChannel @TheRewiredSoul on Twitter and Instagram Join my mailing list: http://eepurl.com/cNH-7r Pick up a copy of my book about overcoming mental illness here: http://amzn.to/2rEXiWi Check out my blog here: http://www.therewiredsoul.com/blog/ The Rewired Soul is an online service helping those dealing with issues of the mind. Chris and his mother Dr. Carrie Randazzo offer courses as well as individual sessions. Visit us at www.TheRewiredSoul.com
Просмотров: 13545 The Rewired Soul
Emerging Issues for Pharma R&D: A Practical Approach for Pediatric Drug Programs
Pediatric patients are not simply small adults. Children differ from adults in both disease pathophysiology and pharmacokinetics/pharmacodynamics (PK/PD). Maturation of metabolic capacity and renal function can impact drug clearance. In addition, changes in body composition can alter volumes of distribution, and changes in GI function can affect drug absorption. Yet historically, 80 percent of medicines used in children had little to no data guiding prescribers on proper use. The pharmaceutical industry has numerous reasons not to develop pediatric drugs. Often, pediatric indications are not particularly profitable, and pediatrics in the US market represents only about seven percent of drug sales. From a practical perspective, pediatric development tends to be a low priority for product development teams who are focused on gaining regulatory approval for adults. To address this market failure, regulatory legislation for drug development in pediatric patients was passed worldwide over the past decade. The number of drugs tested in and labeled for children has increased dramatically as a result. Despite this progress, pediatric drug developers still face numerous hurdles: heterogeneous patient populations, limited numbers of patients, and practical/ethical challenges with performing clinical studies in this vulnerable population. In this webinar, Dr. Barry Mangum from Paidion Research and Dr. JF Marier from Certara discussed how pediatric considerations fit into the overall drug development program. They will also made recommendations for addressing issues from both a practical and scientific perspective. Anonymized case studies were presented with a review of historical issues with a focus on solutions for today (i.e. licensed comparators differences in US and EU, importation issues, and endpoint selection).
Просмотров: 180 Certara